Up a level |
Novello, Silvia and Kaiser, Rolf and Mellemgaard, Anders and Douillard, Jean-Yves and Orlov, Sergey and Krzakowski, Maciej and von Pawel, Joachim and Gottfried, Maya and Bondarenko, Igor and Liao, Meilin and Barrueco, Jose and Gaschler-Markefski, Birgit and Griebsch, Ingolf and Palmer, Michael and Reck, Martin (2015) Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. European Journal of Cancer, V. 51 (Iss. 3). pp. 317-326. ISSN 0959-8049